The National Institute for Clinical Excellence has invited the Lauren Currie Twilight Foundation to a Rituximab consultation in July 2012. The Foundation is delighted that NICE are focusing on Vasculitis and effective treatments. The consultation and assessment from NICE of Vasculitis treatments will have a big impact on patient diagnosis and care and is welcomed by patients across the United Kingdom. The consultation will focus on Rituximab being used with steroids for the treatment of anti-neutrophil cytoplasmic antibody-associated Vasculitis.
The LCT Foundation will take part in the consultation and keep the website updated on progress.